A recent study by US Food and Drug Administration has claimed that leukemia drug ‘Nilotinib’ also has potential of curing acute diseases like dementia and Parkinson’s.
The findings were reported in the Journal of Parkinson’s Disease.
Parkinson’s disease (PD) is the second most common neurodegenerative disorder that causes a range of motor and non-motor symptoms.
During the course of the disease, dopamine (DA)-producing neurons are lost and bundles of proteins known as Lewy Bodies (LBs) form in the brain.
The researchers found that the leukemia drug nilotinib can restore brain dopamine and reduce toxic proteins associated with Lewy Bodies formation in Parkinson’s disease and dementia patients.
(With IANS Inputs)